Scott M.

Scott M. is currently the Executive Director of Quality Assurance and Pharmacovigilance at ReCode Therapeutics. Prior to this role, Scott held positions at various companies such as Alector, BioMarin Pharmaceutical Inc., and a Contract Research Organization, focusing on Quality Assurance in clinical development. In addition, Scott served as the Past President of the Pacific Regional Chapter at the Society of Quality Assurance. Scott has a Master of Science degree in Psychology and Neuroscience from King's College London and completed coursework in Pharmacokinetics at UC San Diego Extended Studies.